Cormorant Asset Management

Cormorant Asset Management

Cormorant Asset Management

Latest investments Show all
$150,000,000
Venture capital (Series E)
Innovent Biologics
$100,000,000
Venture capital
Constellation Pharmaceuticals
Team Size
1–10
Employees
Geographical Focus
Past year's investments
  • 13 rounds in the past year
  • $768.5M deployed in total
  • $59.1M avg per round
Latest rounds
  • Innovent Biologics: Venture capital (Series E) ($150M)
  • Constellation Pharmaceuticals: Venture capital ($100M)
  • Eidos Therapeutics: Venture capital (Series B) ($64M)